N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis (Q48273328)

10 February 2018

title

N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis (English)

1 reference

10 February 2018

1 reference

1 reference

Madsen LH

1

1 reference

10 February 2018

Ladefoged S

2

1 reference

10 February 2018

Corell P

3

1 reference

10 February 2018

Schou M

4

1 reference

10 February 2018

Hildebrandt PR

5

1 reference

10 February 2018

Atar D

6

1 reference

10 February 2018

language of work or name

English

0 references

publication date

14 February 2007

1 reference

10 February 2018

number of pages

7

1 reference

inferred from page(s)

published in

Kidney International

1 reference

10 February 2018

volume

71

1 reference

10 February 2018

issue

6

1 reference

10 February 2018

page(s)

548-554

1 reference

10 February 2018

Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

1 reference

7 January 2021

Essential biochemistry and physiology of (NT-pro)BNP.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

Understanding B-type natriuretic peptide and its role in diagnosing and monitoring congestive heart failure.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

B-type natriuretic peptide and renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

Methods of assessment of volume status and intercompartmental fluid shifts in hemodialysis patients: implications in clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

The prognostic role of brain natriuretic peptides in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

Diagnostic potential of cardiac natriuretic peptides in dialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

B-type natriuretic peptide is related to left ventricular mass in hypertensive patients but not in athletes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

Biochemical diagnosis of impaired left ventricular ejection fraction--comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

N-terminal pro brain natriuretic peptide in arterial hypertension--a marker for left ventricular dimensions and prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

Physiological role of silent receptors of atrial natriuretic factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

Potentiation of natriuretic peptides by neutral endopeptidase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

Diagnosis of heart failure using urinary natriuretic peptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

Renal handling of low molecular weight proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

N-terminal pro-brain natriuretic peptide A new gold standard in predicting mortality in patients with advanced heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: a LIFE study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multi-centre studies (as used in the TRACE study). TRAndolapril Cardiac Evaluation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002087

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5002087

1 reference

10 February 2018

1 reference

10 February 2018